The calcium-sensing receptor (CaS) is the principal controller of extracellular calcium (Ca 21 o ) homeostasis and is inhibited in vitro and in vivo by protein kinase C (PKC)-mediated phosphorylation at CaS T888 . However, PKC inhibition enhances signaling even in CaSs lacking Thr-888, suggesting that an additional inhibitory site exists. An apparently equivalent PKC regulatory site in metabotropic glutamate receptor 5 (Ser-839) aligns not with CaS T888 but instead with CaS S875 , which was not previously considered to be a PKC site. CaS S875A (nonphosphorylatable) exhibited significantly enhanced Ca 21 o sensitivity of both intracellular Ca 21 mobilization and extracellular signal-regulated kinase 1/2 activation, whereas the phosphomimetic CaS S875D mutant exhibited a loss of function. The CaS S875A/T888A double mutant exhibited even greater Ca 21 o sensitivity than CaS T888A alone, a response no longer enhanced by PKC inhibition. Finally, when expressed in CaS lacking its extracellular domain, the CaS S875A/T888A double mutation elicited maximal activation even under control conditions, but remained sensitive to negative allosteric modulation [N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine] or Ca 21 o removal. Therefore, we have now identified CaS S875 as the missing PKC phosphorylation site that, together with CaS T888 , shapes the CaS signaling that underpins Ca 21 o homeostasis. Together with the inactive form of the CaS extracellular domain, these sites attenuate Ca 21 o sensitivity to attain appropriate physiologic Ca 21 o sensing. SIGNIFICANCE STATEMENT Serine-875 represents the missing inhibitory PKC phosphorlyation site in CaS that in tandem with Thr-888 controls receptor activity. s This article has supplemental material available at molpharm.aspetjournals.org.
Introduction
The calcium-sensing receptor (CaS) is the principal controller of extracellular calcium (Ca 21 o ) homeostasis, suppressing both parathyroid hormone secretion and renal calcium reabsorption in response to high Ca 21 o concentration. When first cloned, CaS was predicted to contain five protein kinase C (PKC) consensus sequences: two in the first and third intracellular loops, Thr-646 and Ser-794; and three in the CaS intracellular tail, Thr-888, Ser-895, and Ser-915 (Garrett et al., 1995; Bai et al., 1998) . Previous results from this laboratory and others (Bai et al., 1998; Davies et al., 2007; Young et al., 2014) have shown that one of these residues, CaS T888 , represents the key phosphorylation site responsible for PKC-mediated inhibition of CaS-mediated intracellular Ca 21 (Ca 21 i ) mobilization in vitro. In humans, mutation of CaS T888 to a nonphosphorylatable methionine produces a gain-of-function CaS, resulting in autosomal dominant hypocalcaemia (Lazarus et al., 2011) . Bai et al. (1998) reported that while the other four known PKC sites play little or no role in mediating PKC's functional effect, CaS T888 cannot be the sole determinant of the PKC effect. Furthermore, in the current laboratory, it was shown that CaS T888A still causes Ca 21 i oscillations in some cells (at least in the presence of 2 mM Ca 21 o ), and PKC activation with the phorbol ester phorbol 12myristate 13-acetate (PMA) elicits a partial inhibitory effect in CaS T888A (Davies et al., 2007) and CaS T888M (Lazarus et al., 2011) expressing cells. Together, these findings have suggested the existence of an additional PKC site in CaS.
The idea of PKC-mediated inhibition of class C G proteincoupled receptors (GPCRs) came initially not from CaS but from the structurally homologous metabotropic glutamate receptor 5 (mGluR5) (Dale et al., 2001; Hermans and Challiss, 2001) , with Ser-839 being shown to be the most likely mediator of the PKC response (Kim et al., 2005) . Indeed, mutation of Ser-839 in mGluR5 to alanine (mGluR5 S839A ) was shown to prevent Ca 21 i oscillations in HeLa cells (Kim et al., 2005) . Interestingly, mGluR5 S839 does not align with CaS T888 or indeed with any of the known PKC consensus sequences in the CaS. Instead, it aligns with CaS S875 , a residue not previously considered likely to be a PKC site. In support of this idea, Huttlin et al. (2010) reported murine phospho-proteomic data that included evidence of phosphorylation at CaS S875 . Furthermore, while only five CaS residues were originally proposed to be PKC consensus sequences (Garrett et al., 1995) , the NetPhos database (NetPhos 3.1 Server; http:// www.cbs.dtu.dk/services/NetPhos-3.1/) predicts CaS as having as many as 15 potential PKC sites, including both CaS S875 and CaS T888 .
Therefore, the aim of this study was to evaluate the effect of mutating Ser-875 on CaS-mediated signaling to assess whether it likely represents the missing PKC site (Bai et al., 1998) in the intracellular domain (ICD). This was investigated both in wild-type CaS (CaS WT ) and also in a CaS construct (Rho-C-hCaS) lacking most of the extracellular domain [(ECD), residues 1-599], thus leaving just the seventransmembrane domain (TMD) and N-terminal ICD as described previously (Zhao et al., 1999) .
Materials and Methods
Cell Culture. Human embryonic kidney 293 (HEK-293) cells transfected with CaS WT were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated FBS (Sigma-Aldrich, Gillingham, UK). To avoid cell death, gain-of-function mutant cell lines were routinely cultured in low Ca 21 RPMI (containing 0.42 mM CaCl 2 ) instead of Dulbecco's modified Eagle's medium (containing 1.8 mM CaCl 2 ).
Mutagenesis. Mutations were introduced into the wild-type human parathyroid CaS by site-directed mutagenesis using the Quik-Change lightning site-directed mutagenesis kit in accordance with the manufacturer's instructions (Agilent Technologies Ltd., Cheadle, UK). HEK-293 cells were then transiently transfected with wild-type or mutant receptors using FuGENE6 (Promega, Southampton, UK). For stable expression, vectors were linearized prior to transfection and the resulting CaS-expressing cells were selected using Hygromycin (Duchefa Biochemie). Clonal cell lines were then established. The Rho-C-hCaS mutant was obtained from R. Mun (The Charles Perkins Centre, The University of Sydney, Camperdown, Australia) having been initially generated by Zhao et al. (1999) . All mutations were subsequently verified by the DNA sequencing facility at The University of Manchester.
Immunoblotting. CaS expression was demonstrated by immunoblotting as described previously (Ward et al., 1998) using an anti-CaS mouse monoclonal antibody (ADD; amino acids 214-235 of human CaS; Fisher Scientific, Loughborough, UK). In brief, cells were lysed on ice in a detergent-containing HEPES buffer supplemented with protease inhibitors and 1 mM N-ethylmaleimide. The lysate was centrifuged at 12,000g (for 10 minutes at 4°C) and the supernatant was solubilized in Laemmli buffer at 65°C.
Intracellular Calcium Imaging. CaS-induced Ca 21 i mobilization was assayed by epifluorescence microscopy as described previously (Davies et al., 2007) after loading cells with Fura-2 AM (Life Technologies Ltd., Paisley, UK). CaS-transfected cells were exposed to increasing concentrations of Ca 21 o in experimental buffer [20 mM HEPES (pH 7.4), 125 mM NaCl, 4 mM KCl, 0.5 mM CaCl 2 , 0.5 mM MgCl 2 , and 5.5 mM glucose] at room temperature to compare relative Ca 21 o sensitivities between the receptors. The coverslips were mounted in a perfusion chamber (Warner Instruments, Hamden, CT) and fluorescence visualized using a Nikon Diaphot inverted microscope equipped with a digital camera charge-coupled device.
Extracellular Signal-Regulated Kinase 1/2 Phosphorylation. Extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation in CaS-transfected cells was assayed as described previously (Ward et al., 2002) . In brief, cells were exposed to various concentrations of Ca 21 o in experimental buffer at 37°C for 10 minutes prior to lysis on ice in detergent-containing buffer supplemented with protease and phosphatase inhibitors. ERK1/2 phosphorylation was then determined by semiquantitative immunoblotting using a phosphospecific antibody (Cell Signaling Technology). Data and Statistical Analysis. The data are presented as mean 6 S.D. (for pEC 50 variance; shown as insets in the graphs) or mean 6 S.E.M. (for precision of the individual responses, shown graphically). Statistical significance between pEC 50 values (P values , 0.05) was determined by Student's unpaired/paired t test or one-way ANOVA followed by Dunnett's or Tukey's multiple comparisons test as appropriate (GraphPad Prism version 7). For the Ca 21 i assay, the area under the curve of the Fura-2 ratios (MetaFluor) for all cells in a field of view over a given time range was calculated using GraphPad Prism (version 7) with resulting curves produced using a sigmoidal dose-response (variable slope) equation.
Results
Effect of CaS S875A and CaS S875D Phospho-Mutations on Ca 21 o -Induced Ca 21 i Mobilization.
The key inhibitory PKC site in mGluR5 (mGluR5 S839 ) aligns in the CaS not with the recognized inhibitory PKC site CaS T888 (Bai et al., 1996; Davies et al., 2007) but instead with CaS S875 (Supplemental Fig. 1 ), which has not been previously considered to be a PKC site (Garrett et al., 1995; Bai et al., 1996) . Thus, to examine the potential role of CaS S875 phosphorylation on receptor signaling, this residue was mutated either to a nonphosphorylatable alanine residue (CaS S875A ) or to a phosphomimetic aspartic acid residue (CaS S875D ) in CaS WT . Subsequently, both mutated receptors were transiently transfected into HEK-293 cells, and CaS-induced Ca 21 i mobilization was measured in response to increasing concentrations of Ca 21 o (0.5-10 mM). As shown in Fig. 1 , CaS S875A was a gain-of-function mutation showing enhanced receptor sensitivity to Ca 21 o relative to CaS WT (EC 50 , 2.3 CaS S875A vs. 3.5 mM CaS WT ; P , 0.01). A similar gain of function was seen in HEK-293 cells stably expressing the CaS S875A mutation (Supplemental Figs. 2 and 3) . In contrast, CaS S875D exhibited decreased Ca 21 o sensitivity relative to CaS WT , indicating that it is a loss-of-function mutation (EC 50 , 4.7 CaS S875D vs. 3.5 mM CaS WT ; P , 0.01) ( Fig. 1) .
CaS T888A and CaS S875A Mutations Enhance Ca 21 o -Induced ERK1/2 Phosphorylation. The relative responses of CaS T888A and CaS S875A on Ca 21 o -stimulated ERK1/2 phosphorylation were next compared with CaS WT control responses using HEK-293 cells expressing each receptor stably. In agreement with the Ca 21 i mobilization data, CaS S875A enhanced Ca 21 o -induced phosphorylated ERK1/2 activation relative to CaS WT control (EC 50 , 1.9 CaS S875A vs. 3.8 mM CaS WT ; P , 0.01) ( Fig. 2) . A similar gain of function was seen, as expected, in CaS T888A -expressing cells (EC 50 , 2.2 CaS T888A vs. 4.4 mM CaS WT ; P , 0.01). Equal protein loading on the blots was confirmed by uniform b-actin expression. An equivalent gain of function for Ca 21 i mobilization by the CaS T888A stably expressing cells is shown in Supplemental Fig. 4 . There is evidence that forward trafficking of the CaS can be modulated by its association with 14-3-3 protein under the control of CaS S899 phosphorylation (Grant et al., 2011 (Grant et al., , 2015 . As such, it is important to consider whether CaS S875 phosphorylation affects functional signaling directly or merely as a determinant of cell surface localization. To examine this, HEK-293 cells were transiently transfected with CaS WT , CaS S875A , and CaS T888A , and the membrane localization of these receptors was then analyzed using a surface biotinylation assay. As shown in Supplemental Fig. 5 we saw no evidence of substantive changes in cell surface localization in receptors lacking Ser-875 or Thr-888. However, taken together these observations confirm that CaS S875A is a gain-offunction mutation, with a similar impact on Ca 21 o -stimulated signaling responses to CaS T888A .
Effect of CaS S875A/T888A Double Mutation on CaS Signaling. Since both CaS S875A and CaS T888A exhibited gain of function by two different experimental readouts, it was next decided to introduce both mutations in the same receptor to test whether their effects are additive. This question was asked since Bai et al. (1996) found that PKC inhibition could further enhance CaS T888A signaling, suggesting that another PKC site may contribute additional receptor modulation. The resulting CaS S875A/T888A double mutant was tested for its effect on Ca 21 i mobilization as previously detailed in both transiently (Supplemental Fig. 6 ) and stably transfected ( Fig. 3 ) HEK-293 cells. In both cases, the doubly mutated CaS S875A/T888A exhibited significantly lower EC 50 values and increased sensitivity for Ca 21 o than for the CaS T888A mutant (stable, 1.8 CaS S875A/T888A vs. 2.4 mM CaS T888A ; P , 0.01) ( Fig.  3 ). It was further noted that the CaS S875A/T888A double mutant completely abolished Ca 21 i oscillations, which CaS T888A failed to do at lower Ca 21 o concentrations. Similar to its effect on Ca 21 i mobilization, the CaS S875A/T888A double mutant also increased Ca 21 o sensitivity of ERK1/2 phosphorylation compared with CaS T888A alone (EC 50 , 2.5 vs. Fig. 2 . CaS T888A and CaS S875A mutations increase CaS-induced ERK1/2 phosphorylation. (A) HEK-293 cells were stably transfected with either CaS WT , CaS T888A (i) or CaS S875A (ii), and then stimulated with various Ca 2+ o concentrations (0.5-5 mM) for 10 minutes to determine the effect of mutating the two phosphorylation sites on extracellular signalregulated kinase (pERK) activation. Representative western blots indicating ERK1/2 phosphorylation, together with b-actin loading control, are shown above the resulting concentration-effect curves in each graph. ERK1/2 responses are expressed as a percentage of CaS WT maximal response in each experiment. **P , 0.01 CaS T888A vs. CaS WT (n = 6 from three independent experiments) and CaS S875A vs. CaS WT (n = 7 from three independent experiments) pEC 50 values by unpaired t test, n $ 8 from three independent experiments. (B) CaS immunoblots showing similar receptor abundance between cell lines, with their protein loading equivalence confirmed by b-actin expression. 3.2 respectively; P , 0.05) ( Fig. 3B ), further demonstrating the additive effect of the two mutations. Overall, these observations confirm that the double mutant receptor CaS S875A/T888A was significantly more sensitive to Ca 21 o than CaS T888A alone with respect to both Ca 21 i mobilization and ERK1/2 activation.
To confirm that stable transfection with the double mutant receptor CaS S875A/T888A had not increased Ga q -mediated Ca 21 i mobilization in a nonspecific manner, the effect of carbachol on Ca 21 i mobilization was also tested. Carbachol also elicits oscillatory Ca 21 i mobilization in wild-type HEK-293 cells (Supplemental Fig. 7i ), most likely via the muscarinic acetylcholine receptor (Atwood et al., 2011) . However, the CaS S875A/T888A double mutant failed to increase carbachol sensitivity for Ca 21 i mobilization, suggesting that CaS S875A/T888A gain of function is not due to a nonspecific increase in Ga q -mediated Ca 21 i mobilization or an artifact of transfection (Supplemental Fig. 7 , ii-iv). Indeed, carbachol responsiveness was inhibited in cells expressing CaS S875A/T888A (EC 50 , 7.5 vs. 3.2 mM CaS WT ; P , 0.01). The cause of this reduced carbachol responsiveness was not investigated further.
PKC Inhibition Fails to Further Enhance CaS S875A/T888A Signaling. Having confirmed that the double mutant CaS S875A/T888A exhibits significantly greater Ca 21 o responsiveness than for CaS T888A alone, we next tested whether PKC inhibition could elicit additional signal enhancement suggestive of yet further PKC sites. For this, CaS S875A/T888A stably expressing cells were treated with or without bisindolylmaleimide I [GF109203X (GFX), 250 nM], a nonspecific PKC inhibitor, for 30 minutes, and then co-stimulated with increasing concentrations of Ca 21 o (0.5-5 mM), with Ca 21 i mobilization assayed as previously described (Fig. 4) . For comparison, CaS WT and CaS T888A cells were tested alongside one another in these experiments. As expected, GF109203X treatment significantly increased the sensitivity of both CaS WT (EC 50 ; 5.6 control vs. 3.3 mM GFX; P , 0.001) and CaS T888A (EC 50 ; 2.4 control vs. 1.2 mM GFX; P , 0.001) for Ca 21 o . However, there was no difference in CaS-induced Ca 21 i mobilization between CaS S875A/T888A double mutants treated without or with GF109203X; that is, they both increased CaS sensitivity to a virtually identical extent (EC 50 , 1.8 control vs. 1.7 mM GFX; P 5 0.86). These data suggest that the positive effect of PKC inhibition can be replaced entirely by alanine mutation of both inhibitory phosphorylation sites, Ser-875 and Thr-888, thus indicating that Ser-875 is another PKC site.
Effect of CaS T888A and CaS S875A Mutations on Rho-C-hCaS-Induced Ca 21 i Mobilization. Having established the dual inhibitory effect of CaS T888 and CaS S875 on CaS signaling, the role of both phosphorylation sites was next tested in the context of a CaS construct lacking the entire ECD (Rho-C-hCaS) to assess their inhibitory effects on the TMD core of the receptor. The hypothesis was that if the ECD of the CaS is responsible for ligand-dependent activation (Bräuner-Osborne et al., 1999; Geng et al., 2016; Zhang et al., 2016) , then relieving the PKC-mediated inhibitory constraints on the receptor might result in ligand-independent iv Fig. 3 . CaS S875A/T888A double mutant is more sensitive to Ca 2+ o than CaS T888A alone. (A) Fura-2-loaded HEK-293 cells stably transfected with either CaS T888A (i) or CaS S875A/T888A (ii) were stimulated with increasing Ca 2+ o concentrations (0.5-10 mM). The two panels show Ca 2+ i traces from representative single cells. The resulting concentration-effect curves are shown in (iii). **P , 0.01 for CaS T888A vs. CaS S875A/T888A by unpaired t test; n $ 9 coverslips from three independent experiments. Equivalence of CaS abundance between cell lines is shown in (iv), with b-actin loading control. (B) Representative western blots showing ERK1/2 phosphorylation and b-actin immunoreactivity in the same cell lines as before, stimulated with various Ca 2+ o concentrations (0.5-5 mM) for 10 minutes. The resulting concentration-effect relationship is shown on the right. ERK1/2 responses are expressed as a percentage of CaS T888A maximal response in each experiment. *P , 0.05 EC 50 values for CaS T888A vs. CaS S875A/T888A by unpaired t test; n $ 6 from three independent experiments.
CaS S875 Inhibitory Phosphorylation activation of the CaS. In such a case, mutation of the inhibitory phosphorylation sites might enhance responsiveness even in a headless CaS.
Rho-C-hCaS lacks most of the ECD (residues 1-599); therefore, it contains only the 7TMD and the carboxylterminal ICD with a stop codon at residue 903 as described previously (Zhao et al., 1999) (Supplemental Fig. 8A ). To facilitate cell surface expression, the start of this truncated CaS was fused to 20 amino acid residues of the N-terminus of bovine rhodopsin (MNGTEGPNFYVPFSNKTGVV). First, Rho-C-hCaS was transiently transfected into HEK-293 cells, and then the effect of increasing Ca 21 o concentrations (up to 10 mM) on Ca 21 i mobilization was assayed as previously described. In contrast to CaS WT , which elicits oscillatory signaling, Rho-C-hCaS elicited only transient or sustained Ca 21 i mobilization (Supplemental Fig. 8B ). It should be noted that no Ca 21 i mobilization was seen under these conditions in nontransfected HEK-293 cells (data not shown). Moreover, the effect of PKC inhibition on Rho-C-hCaS signaling was tested. For this, HEK-293 cells transiently transfected with Rho-C-hCaS were first exposed to 3 mM Ca 21 o to elicit Ca 21 i mobilization and then cotreated with 250 nM of GF102903X. Indeed, GF102903X enhanced Rho-C-hCaSinduced Ca 21 i mobilization in response to 3 mM Ca 21 o (P , 0.05) (Supplemental Fig. 8C ).
Next, it was examined whether mutating Thr-888 and/or Ser-875 to alanine can also increase Rho-C-hCaS responsiveness. Compared with the Rho-C-hCaS control, the Rho-C-hCaS T888A mutant was more sensitive to Ca 21 o (EC 50 , 1.8 Rho-C-hCaS T888A vs. 2.8 mM Rho-C-hCaS; P , 0.05) (Fig. 5A) , similar to the effect of T888A in the full-length CaS (Supplemental Fig. 4) . In contrast, Rho-C-hCaS S875A did not exhibit significantly enhanced receptor responsiveness compared with Rho-C-hCaS (EC 50 , 2.4 Rho-C-hCaS S875A vs. 2.8 mM Rho-C-hCaS; P 5 0.18). Therefore, when expressed alone in the headless receptor, only T888A exhibits greater Ca 21 o sensitivity. Fig. 4 . PKC inhibition does not further enhance CaS S875A/T888A responses. Fura-2-loaded HEK-293 cells stably transfected with either CaS WT (A), CaS T888A (B), or CaS S875A/T888A (C) were stimulated with increasing concentrations of Ca 2+ o in the absence or presence of the PKC inhibitor GF109203X (GFX, 250 nM) . The concentration-effect curves show significantly enhanced Ca 2+ o sensitivity following GF109203X treatment in CaS WT and CaS T888A cells but not in CaS S875A/T888A double mutant cells. ***P , 0.001, NS, not significant for control vs. GF109203X by unpaired t test. n $ 6 coverslips from two independent experiments. 
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Effect of Rho-C-hCaS S875A/T888A Double Mutation on Ca 21 i Mobilization. Finally, despite the S875A mutation having no significant effect on Rho-C-hCaS responsiveness on its own, we investigated whether this mutation may potentiate the enhanced responsiveness seen with Rho-C-hCaS T888A when expressed in combination. Indeed, the Rho-C-hCaS S875A/T888A double mutant produced maximal Ca 21 i mobilization even under baseline conditions (0.5 mM Ca 21 o ). However, this effect could be virtually abolished by cotreatment with the CaS negative allosteric modulator (calcilytic) N-(2-hydroxy-3-(2cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine (1 mM; P , 0.001) (Fig. 6B) . To determine whether the Rho-C-hCaS S875A/T888A double mutant is constitutively active, i.e., elicits continuous signaling even in the absence of an agonist, Ca 21 i mobilization was tested using a buffer that was nominally free of Ca 21 or Mg 21 . As shown in Fig. 6 , the Rho-C-hCaS S875A/T888A -induced Ca 21 i mobilization elicited in control buffer (0.5 mM Ca 21 ) was almost abolished upon removal of Ca 21 o and extracellular Mg 21 (P , 0.001). Interestingly, introduction of 0.5 mM Mg 21 alone was sufficient to elicit cellular Ca 21 i transients in some coverslips. Subsequent introduction of 0.5 mM Ca 21 restored maximal activation of the Rho-C-hCaS S875A/T888A double mutant. Thus, although Rho-C-hCaS S875A/T888A was not constitutively active, it exhibited substantially enhanced sensitivity to Ca 21 o (i.e., with a presumed EC 50 , 0.5 mM) despite the absence of an ECD. Together, these data demonstrate the importance of PKC-mediated Ser-875 and Thr-888 phosphorylation in the control of CaS signaling.
Discussion
Initial sequence analysis of the human CaS predicted that only five of the intracellular serine/threonine residues were likely to be PKC phosphorylation sites: two in the first and third intracellular loops (Thr-646 and Ser-794) and three in the ICD (Thr-888, Ser-895, and Ser-915) of the receptor (Garrett et al., 1995; Bai et al., 1998) . Previous results have shown that one of these, CaS T888 , represents the key phosphorylation site responsible for PKC-mediated inhibition of CaS-mediated Ca 21 i mobilization (Bai et al., 1998; Davies et al., 2007; Young et al., 2014) . However, it should be noted that the human CaS has in fact 54 serine and threonine residues in either its ICD or three intracellular loops, although no tyrosine residues (Garrett et al., 1995) . The NetPhos database predicts that 40 of these sites reach the threshold for being potential phosphorylation sites for at least one out of a panel of 17 protein kinases (http://www.cbs.dtu.dk/ services/NetPhos-3.1/). Interestingly, all of the serine/threonine residues in the juxtamembrane region of the ICD (residues 863-920) are predicted to be phosphorylation sites for one protein kinase or another, whereas in the later carboxyl-terminus few such residues are likely phosphorylation sites. In addition, this database predicts not five PKC sites in the CaS but 15 (including Ser-875), although it should also be noted that these predictions are based on primary sequence and do not take into account site accessibility or location. Nevertheless, current consensus site prediction databases indicate much greater scope for CaS phosphorylation than was considered when CaS was first cloned.
It has been suggested that where GPCRs have a variety of potential kinase consensus sequences, the precise pattern of phosphorylation on any given receptor could be quite different in different cellular contexts. The so-called phospho-barcode hypothesis posits that different patterns of phosphorylation could elicit distinct downstream signaling outcomes (Tobin et al., 2008; Yang et al., 2017) . The barcode hypothesis was first devised by studying two GPCRs: the muscarinic acetylcholine receptor (Butcher et al., 2011) and the b2-adrenergic receptor (Nobles et al., 2011) . The present findings indicate CaS S875 Inhibitory Phosphorylation that the CaS may also exhibit distinct phospho-barcodes in different cell types and/or following exposure to biased agonists or cotreatments with other GPCR agonists.
Consistent with the NetPhos database prediction and the current data, a phospho-proteomic study using mass spectrometry to detect phosphorylation sites in nine different organs from 3-week-old male mice has previously determined CaS S875 as a phosphorylation site in the kidney (Huttlin et al., 2010) . This demonstrates that CaS S875 is capable of being phosphorylated in vivo. In addition, sequence alignment analysis of the ICDs of the CaS with the structurally homologous mGluR5 confirms that CaS Ser-875 is equivalent to the principal PKC phosphorylation site in mGluR5, namely, Ser-839 (MEGA-X software) (Supplemental Fig. 1A ). Therefore, the alignment of CaS S875 and mGluR5 S839 suggests that they share similar regulatory roles in the modulation of receptor signaling. Moreover, the amino acid conservation of the putative Ser-875 phosphorylation site was examined in the current study across a previously published multiple sequences alignment of 51 different vertebrate CaS species (Herberger and Loretz, 2013) using the free WebLogo analysis website (https://weblogo.berkeley.edu/logo.cgi). As reflected by the high WebLogo bit scores (Supplemental Fig. 1B) , CaS S875 is well conserved within different species. Overall, the conservation of Ser-875 is consistent with the phosphorylation site prediction and the strong functional role in CaS signaling. One important consideration regarding these phosphorylation sites is to determine whether they modulate signal transduction directly or instead by altering CaS cell surface localization (Breitwieser, 2013) , as is apparently the case for CaS S899 (Grant et al., 2015) . In this regard, we did not see a significant difference in the surface biotinylation of CaS S875A or CaS T888A versus CaS WT receptors. Nevertheless, it would be helpful to have a more thorough analysis of the effect of these and other CaS phospho-site point mutations on receptor maturation, forward trafficking, agonist-driven insertional signaling, internalization, and desensitization. However, in the meantime the current data establish a clear link between residues CaS S875 and CaS T888 and CaS downstream signaling.
In agreement with our previous study (Davies et al., 2007) , CaS T888A elicits more sustained Ca 21 i mobilization than CaS WT . However, at lower Ca 21 o concentrations (1.5-2.5 mM) Ca 21 i oscillations continued in some CaS T888A -expressing cells. Young et al. (2002) did not observe such oscillations in CaS T888A -expressing cells, although only 3 mM Ca 21 o was used to stimulate the receptor in that study, and in our experiments 3 mM Ca 21 o also elicited only sustained Ca 21 i mobilization with CaS T888A . Significantly, the persistence of Ca 21 i oscillations in CaS T888A -transfected cells suggests that this site alone cannot be the exclusive phosphorylation location controlling Ca 21 i oscillations (Davies et al., 2007) , meaning that an additional signaling determinant is required.
In support of this idea, Bai et al. (1998) previously showed that PKC activation by PMA reduced the responsiveness of a mutant CaS, in which all five predicted PKC sites were eliminated. Moreover, PMA elicited a partial inhibitory effect in cells expressing CaS T888A (Davies et al., 2007) and CaS T888M (Lazarus et al., 2011) . Because PMA increases the phosphorylation of serine/threonine residues, these preserved inhibitory effects could be explained by the presence of an additional, previously unidentified PKC site(s) on the CaS.
As such, the current results indicate that Ser-875 is the previously unidentified PKC site. Specifically, CaS S875A with its nonphosphorylatable mutation enhanced signaling, whereas CaS S875D with its phosphomimetic mutation inhibited signaling. Furthermore, the CaS S875A/T888A double mutation further enhanced both Ca 21 o -induced Ca 21 i mobilization and ERK1/2 phosphorylation more than for CaS T888A alone, whereas concomitant PKC inhibition had no further effect. To prove that CaS S875 is a PKC site and then determine the ligand sensitivity of such phosphorylation, as was done for CaS T888 (Davies et al., 2007; McCormick et al., 2010) , it will be necessary to raise a phospho-CaS S875 -specific antibody. However, our initial attempt to generate such an antibody proved unsuccessful, and thus we must rely instead on the mutagenesis studies reported herein, the new consensus predictions described previously, the alignment to mGluR5 S839 , and the previous murine proteomic data (Huttlin et al., 2010) . On balance, we would argue that the simplest explanation of the current data is that CaS S875 is a functionally important PKC site, in conjunction with CaS T888 . However, the possible involvement of other phosphorylation sites in the regulation of CaS function awaits determination.
That CaS S875A/T888A expression failed to enhance carbachol signaling supported the idea that the gain of function was CaS specific and not an artifact of transfection. However, the observation that CaS S875A/T888A expression, in fact, inhibited carbachol signaling is interesting. It is proposed that receptors exist in a conformational equilibrium between inactive and active states, and that G proteins have higher affinity for the active state of the receptor (Burstein et al., 1995) . Since both CaS and the muscarinic acetylcholine receptor are Ga q coupled, it seems feasible that they compete for the same Ga q -protein pool (Linderman, 2009) , and thus perhaps Ga q has sufficiently higher affinity for the hyperactive CaS S875A/T888A double mutant, such that fewer Ga q proteins were available to elicit the carbachol response. This issue requires further study.
Consistent with Mun et al. (2004) , the Rho-C-hCaS mutant was sensitive to increasing concentrations of Ca 21 o , which further verified the existence of at least one Ca 21 o -binding site in the 7TMD of the CaS (Hammerland et al., 1999; Hu et al., 2002; Ray and Northup, 2002) . This confirmation of the functional activity of the Rho-C-hCaS mutant allowed the determination of the role of PKC phosphorylation sites in a functionally active CaS that was not subject to control by the ECD. Introducing the mutation T888A to Rho-C-hCaS increased its Ca 21 o sensitivity to that seen for the full-length CaS T888A . Although Rho-C-hCaS S875A did not, on its own, enhance Ca 21 o sensitivity (we observed a trend in this direction), the Rho-C-hCaS S875A/T888A exhibited maximal Ca 21 i responsiveness even in control buffer. The response did not represent constitutive activity since Rho-C-hCaS S875A/T888A could be suppressed by both calcilytic [N-(2-hydroxy-3-(2-cyano-3chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine] cotreatment and exposure to nominally Ca 21 /Mg 21 -free buffer. These findings suggest that the TMD/proximal ICD core of the CaS might be much more Ca 21 o sensitive than is generally appreciated, and that the inactive form of the ECD and activation of the two PKC phosphorylation sites arrest its responsiveness. In summary, the present study has identified CaS S875 as a phosphorylation site that together with CaS T888 acts as a negative controller of CaS signaling and maintains Ca 21 o -stimulated Ca 21 i oscillations that underpin CaS-mediated control of Ca 21 o homeostasis.
